FAST NEWS: Antengene Invests $36 Million in Drug Discovery Center
The latest: Biopharma company Antengene Corp. Ltd. (6996.HK) announced Monday it has entered into an agreement with a contractor to build a drug discovery and manufacturing center for antibody biologics in…
RELATED ARTICLES
-
FAST NEWS: Antengene appoints Hansoh to commercialize myeloma drug
6996.HK
-
FAST NEWS: Antengene’s loss widens on lower forex income, rising R&D costs
6996.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
-
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: Ascentage’s manufacturing center gets EU stamp of approval
6855.HK
-
Everest reaches new heights on growing drug sales
1952.HK
Discover hidden China stock gems in our weekly newsletter